CONTEXT: Fluorescence molecular tomography (FMT) is a powerful near-infrared modality that produces 3D quantitative images of fluorochrome distribution in live small animals. Bone morphogenetic protein-2 (BMP-2) has been used clinically to induce bone and cartilage formation.
CONTEXT: Fluorescence molecular tomography (FMT) is a powerful near-infrared modality that produces 3D quantitative images of fluorochrome distribution in live small animals. Bone morphogenetic protein-2 (BMP-2) has been used clinically to induce bone and cartilage formation. Genetically engineered cells expressing BMP-2 (C9 cells) have been shown to induce bone growth in animal models. To acquire quantitative imaging in vivo of this bone formation process, researchers at VisEn Medical in Woburn, MA, set out to demonstrate the feasibility of 3D FMT.
RESULTS: Working in collaboration with Dr. Yoram Zilberman at Hebrew University in Jerusalem, the VisEn team studied two mouse models: one to image ectopic bone growth in the thigh, and one to evaluate bone repair in a radius nonunion fracture in response to locally implanted C9 cells at the two sites. Researchers administered OsteoSense, a fluorescent diphosphonate imaging agent, before FMT scans on days seven, 14, and 21. OsteoSense binds to hydroxyapatite, a mineral produced during bone formation. Signal increased on day 14 and stabilized thereafter in the thigh, while it continued to increase on day 21 at the site of the fracture. Postmortem microCT analysis on day 21 and histology confirmed the formation of bone in the thigh muscle and in the fracture, correlating to results acquired through FMT.
IMAGE: Central coronal slice from in vivo FMT reconstruction (left) indicates high hydroxyapatite deposition and labeling in the radial fracture site at day 14. Postmortem microCT (middle) shows new bone formation at the nonunion radial fracture site at day 21. Correlative histology (right) confirms the formation of new bone (B) between the dissected edges of the radius (X, only one edge shown at this magnification).
IMPLICATIONS: Results demonstrate for the first time that 3D optical molecular imaging can visualize and quantify the formation of new bone in vivo. Dr. Wael Yared, lead researcher from VisEn, foresees extending FMT to the study of cancer and to additional research on bone regeneration and tissue engineering.
Can Photon-Counting CT be an Alternative to MRI for Assessing Liver Fat Fraction?
March 21st 2025Photon-counting CT fat fraction evaluation offered a maximum sensitivity of 81 percent for detecting steatosis and had a 91 percent ICC agreement with MRI proton density fat fraction assessment, according to new prospective research.
The Reading Room Podcast: Current Perspectives on the Updated Appropriate Use Criteria for Brain PET
March 18th 2025In a new podcast, Satoshi Minoshima, M.D., Ph.D., and James Williams, Ph.D., share their insights on the recently updated appropriate use criteria for amyloid PET and tau PET in patients with mild cognitive impairment.
Strategies to Reduce Disparities in Interventional Radiology Care
March 19th 2025In order to help address the geographic, racial, and socioeconomic barriers that limit patient access to interventional radiology (IR) care, these authors recommend a variety of measures ranging from increased patient and physician awareness of IR to mobile IR clinics and improved understanding of social determinants of health.
AI-Initiated Recalls After Screening Mammography Demonstrate Higher PPV for Breast Cancer
March 18th 2025While recalls initiated by one of two reviewing radiologists after screening mammography were nearly 10 percent higher than recalls initiated by an AI software, the AI-initiated recalls had an 85 percent higher positive predictive value for breast cancer, according to a new study.